Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Antonio Jimeno-Largo

TitleProfessor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED
Phone303/724-2478

    Collapse Research 
    Collapse research activities and funding
    P50CA261605     (JIMENO, ANTONIO ;WANG, XIAO-JING)Sep 1, 2021 - Aug 31, 2026
    NIH
    Colorado Head and Neck Cancer SPORE
    Role: Principal Investigator

    R01DE030683     (JIMENO, ANTONIO)Apr 1, 2021 - Mar 31, 2026
    NIH
    Targeting oncogenic Myb fusions in salivary gland cancer with the elongation inhibitor SVC112
    Role: Principal Investigator

    T32CA236734     (DAVILA, EDUARDO V;JIMENO, ANTONIO)Jul 8, 2019 - Jun 30, 2024
    NIH
    Cancer Immunotherapy and Experimental Therapeutics - T32
    Role: Principal Investigator

    R01CA213102     (JIMENO, ANTONIO)Aug 1, 2017 - Jul 31, 2021
    NIH
    Development of an autologous humanized model of melanoma exploring human thymic education capacity
    Role: Principal Investigator

    R01DE024371     (WANG, XIAO-JING)Aug 1, 2014 - Jul 31, 2019
    NIH
    Identifying oral cancer stem cell properties affected by the microenvironment
    Role: Co-Principal Investigator

    R56DE023245     (REYLAND, MARY ELAINE)Sep 26, 2012 - Aug 31, 2015
    NIH
    Functional characterization of salivary gland cancers and development of patient
    Role: Co-Principal Investigator

    R21CA156114     (JIMENO, ANTONIO)Sep 8, 2011 - Aug 31, 2014
    NIH
    Rational combination of EGFR and Hedgehog inhibitors in head and neck cancer
    Role: Principal Investigator

    R01CA149456     (JIMENO, ANTONIO)Aug 9, 2010 - May 31, 2022
    NIH
    Characterizing the regulation of PD-1 ligands in head and neck cancer stem cells using an autologous humanized model with T cell education capability
    Role: Principal Investigator

    R21DE019712     (JIMENO, ANTONIO)Sep 1, 2009 - Aug 31, 2012
    NIH
    Rational generation of a head and neck squamous cell cancer direct xenograft mode
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Jimeno A, Baranda J, Iams WT, Park JC, Mita M, Gordon MS, Taylor M, Dhani N, Leal AD, Neupane P, Eng C, Yeku O, Mita A, Moser JC, Butler M, Loughhead SM, Jennings J, Miselis NR, Ji RR, Nair N, Kornacker M, Zwirtes RF, Bernstein H, Sharei A. Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumors. Invest New Drugs. 2023 04; 41(2):284-295. PMID: 36867316.
      View in: PubMed
    Jimeno-Largo's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)